(Q34449958)

2 August 2017

title

The addition of prazosin to standard triple therapy in the treatment of severe hypertension (English)

1 reference

2 August 2017

Heagerty AM

1

1 reference

2 August 2017

Russell GI

2

1 reference

2 August 2017

Bing RF

3

1 reference

2 August 2017

Thurston H

4

1 reference

2 August 2017

Swales JD

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1982

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

13

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

539-541

1 reference

Minoxidil and the treatment of severe hypertension

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Partial versus complete control of blood pressure in the prevention of hypertensive complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Effects of prazosin on forearm resistance and capacitance vessels

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Prazosin: the first-dose phenomenon

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Captopril in the treatment of clinical hypertension and cardiac failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402042

CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01418.X

Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7066169

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hydrallazine in hypertension: is there a safe dose?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7066169

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1982.TB01418.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference